ID   TP4A1_HUMAN             Reviewed;         173 AA.
AC   Q93096; B2R6C8; O00648; Q49A54;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Protein tyrosine phosphatase type IVA 1;
DE            EC=3.1.3.48;
DE   AltName: Full=PTP(CAAXI);
DE   AltName: Full=Protein-tyrosine phosphatase 4a1;
DE   AltName: Full=Protein-tyrosine phosphatase of regenerating liver 1;
DE            Short=PRL-1;
DE   Flags: Precursor;
GN   Name=PTP4A1; Synonyms=PRL1, PTPCAAX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ENZYME ACTIVITY, AND ISOPRENYLATION AT
RP   CYS-170.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9018080; DOI=10.1016/S0304-3835(96)04459-X;
RA   Cates C.A., Michael R.L., Stayrook K.R., Harvey K.A., Burke Y.D.,
RA   Randall S.K., Crowell P.L., Crowell D.N.;
RT   "Prenylation of oncogenic human PTP(CAAX) protein tyrosine
RT   phosphatases.";
RL   Cancer Lett. 110:49-55(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Regenerating liver;
RX   PubMed=9642300; DOI=10.1074/jbc.273.27.17286;
RA   Peng Y., Genin A., Spinner N.B., Diamond R.H., Taub R.;
RT   "The gene encoding human nuclear protein tyrosine phosphatase, PRL-1.
RT   Cloning, chromosomal localization, and identification of an intron
RT   enhancer.";
RL   J. Biol. Chem. 273:17286-17295(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 80-163.
RC   TISSUE=Lung fibroblast;
RX   PubMed=9633825;
RA   Dayton M.A., Knobloch T.J.;
RT   "Multiple phosphotyrosine phosphatase mRNAs are expressed in the human
RT   lung fibroblast cell line WI-38.";
RL   Recept. Signal Transduct. 7:241-256(1997).
RN   [9]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=10940933;
RX   DOI=10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J;
RA   Gjoerloff-Wingren A., Saxena M., Han S., Wang X., Alonso A.,
RA   Renedo M., Oh P., Williams S., Schnitzer J., Mustelin T.;
RT   "Subcellular localization of intracellular protein tyrosine
RT   phosphatases in T cells.";
RL   Eur. J. Immunol. 30:2412-2421(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF ASP-71;
RP   ASP-72; CYS-104; CYS-170 AND CYS-171, INTERACTION WITH TUBULIN, AND
RP   FUNCTION.
RX   PubMed=12235145; DOI=10.1074/jbc.M206407200;
RA   Wang J., Kirby C.E., Herbst R.;
RT   "The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum
RT   and the mitotic spindle and is required for normal mitosis.";
RL   J. Biol. Chem. 277:46659-46668(2002).
RN   [11]
RP   ENZYME REGULATION.
RX   PubMed=12516958;
RA   Pathak M.K., Dhawan D., Lindner D.J., Borden E.C., Farver C., Yi T.;
RT   "Pentamidine is an inhibitor of PRL phosphatases with anticancer
RT   activity.";
RL   Mol. Cancer Ther. 1:1255-1264(2002).
RN   [12]
RP   FUNCTION.
RX   PubMed=14643450; DOI=10.1016/S0304-3835(03)00517-2;
RA   Werner S.R., Lee P.A., DeCamp M.W., Crowell D.N., Randall S.K.,
RA   Crowell P.L.;
RT   "Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1)
RT   by PRL tyrosine phosphatases.";
RL   Cancer Lett. 202:201-211(2003).
RN   [13]
RP   FUNCTION.
RX   PubMed=12782572;
RA   Zeng Q., Dong J.-M., Guo K., Li J., Tan H.-X., Koh V., Pallen C.J.,
RA   Manser E., Hong W.;
RT   "PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.";
RL   Cancer Res. 63:2716-2722(2003).
RN   [14]
RP   INDUCTION.
RX   PubMed=15501285; DOI=10.1016/j.toxicon.2004.07.018;
RA   Raghavendra Prasad H.S., Qi Z., Srinivasan K.N., Gopalakrishnakone P.;
RT   "Potential effects of tetrodotoxin exposure to human glial cells
RT   postulated using microarray approach.";
RL   Toxicon 44:597-608(2004).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF MUTANT SER-104, DISULFIDE
RP   BOND, SUBCELLULAR LOCATION, SUBUNIT, MUTAGENESIS OF THR-13 AND
RP   GLN-131, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15571731; DOI=10.1016/j.jmb.2004.10.061;
RA   Jeong D.G., Kim S.J., Kim J.H., Son J.H., Park M.R., Lim S.M.,
RA   Yoon T.-S., Ryu S.E.;
RT   "Trimeric structure of PRL-1 phosphatase reveals an active enzyme
RT   conformation and regulation mechanisms.";
RL   J. Mol. Biol. 345:401-413(2005).
CC   -!- FUNCTION: Protein tyrosine phosphatase which stimulates
CC       progression from G1 into S phase during mitosis. May play a role
CC       in the development and maintenance of differentiating epithelial
CC       tissues. Enhances cell proliferation, cell motility and invasive
CC       activity, and promotes cancer metastasis.
CC       {ECO:0000269|PubMed:12235145, ECO:0000269|PubMed:12782572,
CC       ECO:0000269|PubMed:14643450}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000269|PubMed:9018080}.
CC   -!- ENZYME REGULATION: Inhibited by sodium orthovanadate and
CC       pentamidine. {ECO:0000269|PubMed:12516958}.
CC   -!- SUBUNIT: Homotrimer. Interacts with ATF5 (By similarity).
CC       Interacts with tubulin. {ECO:0000250, ECO:0000269|PubMed:12235145,
CC       ECO:0000269|PubMed:15571731}.
CC   -!- INTERACTION:
CC       Q9NRU3:CNNM1; NbExp=4; IntAct=EBI-1058467, EBI-11986439;
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Early endosome. Endoplasmic
CC       reticulum. Cytoplasm. Cytoplasm, cytoskeleton, spindle. Note=And
CC       mitotic spindle.
CC   -!- TISSUE SPECIFICITY: Expressed in bone marrow, lymph nodes, T
CC       lymphocytes, spleen, thymus and tonsil. Overexpressed in tumor
CC       cell lines. {ECO:0000269|PubMed:10940933,
CC       ECO:0000269|PubMed:12235145}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal liver.
CC       {ECO:0000269|PubMed:10940933}.
CC   -!- INDUCTION: Strongly down-regulated upon tetrodotoxin treatment.
CC       {ECO:0000269|PubMed:15501285}.
CC   -!- PTM: Farnesylated. Farnesylation is required for membrane
CC       targeting. Unfarnesylated forms are shifted into the nucleus.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U48296; AAB40597.1; -; mRNA.
DR   EMBL; AF051160; AAC39836.1; -; Genomic_DNA.
DR   EMBL; AK312526; BAG35425.1; -; mRNA.
DR   EMBL; CR749458; CAH18292.1; -; mRNA.
DR   EMBL; AL135905; CAC12761.1; -; Genomic_DNA.
DR   EMBL; CH471143; EAW88494.1; -; Genomic_DNA.
DR   EMBL; BC023975; AAH23975.1; -; mRNA.
DR   EMBL; BC045571; AAH45571.1; -; mRNA.
DR   EMBL; U69701; AAB09080.1; -; mRNA.
DR   CCDS; CCDS4965.1; -.
DR   RefSeq; NP_003454.1; NM_003463.4.
DR   RefSeq; XP_011534413.1; XM_011536111.1.
DR   RefSeq; XP_011534414.1; XM_011536112.1.
DR   RefSeq; XP_016866759.1; XM_017011270.1.
DR   RefSeq; XP_016866760.1; XM_017011271.1.
DR   UniGene; Hs.227777; -.
DR   UniGene; Hs.706850; -.
DR   PDB; 1RXD; X-ray; 1.90 A; A/B/C=2-160.
DR   PDB; 1XM2; X-ray; 2.70 A; A/B/C/D/E/F=1-173.
DR   PDB; 5BX1; X-ray; 1.90 A; A=4-160.
DR   PDBsum; 1RXD; -.
DR   PDBsum; 1XM2; -.
DR   PDBsum; 5BX1; -.
DR   ProteinModelPortal; Q93096; -.
DR   SMR; Q93096; -.
DR   BioGrid; 113578; 18.
DR   IntAct; Q93096; 8.
DR   MINT; MINT-194351; -.
DR   STRING; 9606.ENSP00000359685; -.
DR   BindingDB; Q93096; -.
DR   ChEMBL; CHEMBL1075169; -.
DR   DEPOD; Q93096; -.
DR   iPTMnet; Q93096; -.
DR   PhosphoSitePlus; Q93096; -.
DR   DMDM; 68566217; -.
DR   EPD; Q93096; -.
DR   MaxQB; Q93096; -.
DR   PaxDb; Q93096; -.
DR   PeptideAtlas; Q93096; -.
DR   PRIDE; Q93096; -.
DR   DNASU; 7803; -.
DR   Ensembl; ENST00000370651; ENSP00000359685; ENSG00000112245.
DR   Ensembl; ENST00000626021; ENSP00000485687; ENSG00000112245.
DR   GeneID; 7803; -.
DR   KEGG; hsa:7803; -.
DR   UCSC; uc003pel.5; human.
DR   CTD; 7803; -.
DR   DisGeNET; 7803; -.
DR   GeneCards; PTP4A1; -.
DR   HGNC; HGNC:9634; PTP4A1.
DR   HPA; HPA003281; -.
DR   MIM; 601585; gene.
DR   neXtProt; NX_Q93096; -.
DR   OpenTargets; ENSG00000112245; -.
DR   PharmGKB; PA33977; -.
DR   eggNOG; KOG2836; Eukaryota.
DR   eggNOG; ENOG4111I7J; LUCA.
DR   GeneTree; ENSGT00390000009788; -.
DR   HOGENOM; HOG000231265; -.
DR   HOVERGEN; HBG071295; -.
DR   InParanoid; Q93096; -.
DR   KO; K18041; -.
DR   OMA; ETIAVHC; -.
DR   OrthoDB; EOG091G0MYM; -.
DR   PhylomeDB; Q93096; -.
DR   TreeFam; TF313384; -.
DR   BRENDA; 3.1.3.16; 2681.
DR   SIGNOR; Q93096; -.
DR   ChiTaRS; PTP4A1; human.
DR   EvolutionaryTrace; Q93096; -.
DR   GeneWiki; PTP4A1; -.
DR   GenomeRNAi; 7803; -.
DR   PRO; PR:Q93096; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112245; -.
DR   CleanEx; HS_PTP4A1; -.
DR   ExpressionAtlas; Q93096; baseline and differential.
DR   Genevisible; Q93096; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0030335; P:positive regulation of cell migration; IBA:GO_Central.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00782; DSPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell cycle; Cell membrane; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Hydrolase; Lipoprotein; Membrane;
KW   Methylation; Prenylation; Protein phosphatase; Reference proteome.
FT   CHAIN         1    170       Protein tyrosine phosphatase type IVA 1.
FT                                /FTId=PRO_0000094780.
FT   PROPEP      171    173       Removed in mature form. {ECO:0000305}.
FT                                /FTId=PRO_0000396726.
FT   DOMAIN       82    148       Tyrosine-protein phosphatase.
FT   REGION       97    132       Interaction with ATF5. {ECO:0000250}.
FT   REGION      105    110       Phosphate binding.
FT   ACT_SITE     72     72       Proton donor. {ECO:0000305}.
FT   ACT_SITE    104    104       Phosphocysteine intermediate.
FT   BINDING     110    110       Substrate.
FT   MOD_RES     170    170       Cysteine methyl ester. {ECO:0000305}.
FT   LIPID       170    170       S-farnesyl cysteine.
FT                                {ECO:0000269|PubMed:9018080}.
FT   DISULFID     49    104       {ECO:0000269|PubMed:15571731}.
FT   MUTAGEN      13     13       T->F: Reduces trimerization.
FT                                {ECO:0000269|PubMed:15571731}.
FT   MUTAGEN      71     71       D->A: No effect on catalytic activity.
FT                                {ECO:0000269|PubMed:12235145}.
FT   MUTAGEN      72     72       D->A: 80% loss of catalytic activity;
FT                                delay in progression through G2/M.
FT                                {ECO:0000269|PubMed:12235145}.
FT   MUTAGEN     104    104       C->S: Abolishes enzymatic activity.
FT                                {ECO:0000269|PubMed:12235145}.
FT   MUTAGEN     131    131       Q->A: Reduces trimerization.
FT                                {ECO:0000269|PubMed:15571731}.
FT   MUTAGEN     170    170       C->S: Redistributes to the nucleus in
FT                                resting cells, but still locates to the
FT                                mitotic spindle in dividing cells.
FT                                Induces defects in cytokinesis.
FT                                {ECO:0000269|PubMed:12235145}.
FT   MUTAGEN     171    171       C->S: No effect on subcellular location.
FT                                {ECO:0000269|PubMed:12235145}.
FT   STRAND       10     14       {ECO:0000244|PDB:1RXD}.
FT   STRAND       17     21       {ECO:0000244|PDB:1RXD}.
FT   HELIX        27     29       {ECO:0000244|PDB:1RXD}.
FT   HELIX        30     39       {ECO:0000244|PDB:1RXD}.
FT   STRAND       42     47       {ECO:0000244|PDB:1RXD}.
FT   HELIX        56     60       {ECO:0000244|PDB:1RXD}.
FT   STRAND       64     67       {ECO:0000244|PDB:1RXD}.
FT   STRAND       72     74       {ECO:0000244|PDB:1XM2}.
FT   HELIX        78     94       {ECO:0000244|PDB:1RXD}.
FT   STRAND       99    103       {ECO:0000244|PDB:1RXD}.
FT   STRAND      105    108       {ECO:0000244|PDB:1RXD}.
FT   TURN        109    111       {ECO:0000244|PDB:1RXD}.
FT   HELIX       112    121       {ECO:0000244|PDB:1RXD}.
FT   HELIX       126    134       {ECO:0000244|PDB:1RXD}.
FT   HELIX       143    151       {ECO:0000244|PDB:1RXD}.
SQ   SEQUENCE   173 AA;  19815 MW;  702008013D3F3835 CRC64;
     MARMNRPAPV EVTYKNMRFL ITHNPTNATL NKFIEELKKY GVTTIVRVCE ATYDTTLVEK
     EGIHVLDWPF DDGAPPSNQI VDDWLSLVKI KFREEPGCCI AVHCVAGLGR APVLVALALI
     EGGMKYEDAV QFIRQKRRGA FNSKQLLYLE KYRPKMRLRF KDSNGHRNNC CIQ
//
